HW461
WINS OF CHANGE
(
Former
CDC Director Robert Redfield Rewrites the Record; RFK Jr.'s Announcement of 21 new
members of the Interagency Autism Coordinating Committee (IACC); Moderna’s
Announcement that it is halting new Phase 3 Vaccine Trials, Citing Reduced
Market Incentives under Increased Federal Oversight; The Wellness Group’s
Wellingineering
Bet;
THE
U.S. NAVY APOLOGIZES FOR HARMFUL COVID POLICIES; STATE BY STATE: THE BATTLE FOR
MEDICAL FREEDOM CONTINUES;
THE PANOPTICON STATE: UK’S AI SURVEILLANCE EXPANSION;
THE REAL VICTIMS OF The MINNESOTa Bogus FRAUD SCANDAL
are children
Former CDC Director Robert Redfield is
now saying the quiet part out loud, admitting we were right about mRNA and
spike protein.
DR
REDFIELD REWRITES THE RECORD
Former CDC Director Robert Redfield’s recent, startling
admissions about the COVID-19 mRNA vaccines raise a critical question: how
different might the COVID era have been if the public had been told early on
that these shots were never designed to stop transmission and were not
appropriate for children?
Arizona
Bill Labels mRNA as Bioweapons: What the Text Says, What the Evidence Shows
The
statutory text advances assertions, not empirical findings. It claims that
modified mRNA:
Is gene
altering, based on nucleotide modification (e.g., N1-methyl-pseudouridine).
Produces
pathogenic spike protein for prolonged periods.
Involves
nanotechnology capable of altering genes or creating biosynthetic replication.
Crucially,
these claims are not supported in the bill by citations to peer-reviewed
clinical trials, pharmacokinetic studies, toxicology data, or regulatory safety
assessments.
Del Celebrates RFK Jr.'s Announcement
of 21 new members of the Interagency Autism Coordinating Committee (IACC), the
committee responsible for coordinating the government’s autism research and
response. This is huge, and Del has the details.
RFK
JR’S HHS ANNOUNCES NEW MEMBERS TO CRITICAL AUTISM COMMITTEE
A pivotal shift is unfolding as new leadership is installed
at the Interagency Autism Coordinating Committee (IACC) which is responsible
for coordinating the government’s Autism response, policy, and research across
all Government Agencies.
New Aluminum Adjuvant Study and Autism
Converging mechanistic, neuropathological, epidemiological, and genetic evidence demonstrates that aluminum adjuvants can trigger ASD in genetically susceptible individuals through well-characterized neuroinflammatory pathways. The 80-fold increase in ASD prevalence temporally correlating with vaccine schedule expansion, combined with robust biological mechanisms and postmortem findings, demands urgent re-examination of aluminum adjuvant safety in the context of neurodevelopment, particularly in genetically vulnerable populations.
We examine Moderna’s announcement that
it is halting new Phase 3 vaccine trials, citing reduced market incentives
under increased federal oversight. What does this decision reveal about safety
testing, accountability, and public health priorities?
NO
MANDATES, NO PROFITS: MODERNA CEO TELLS THE TRUTH
As the U.S. withdraws from the World Health Organization,
Moderna CEO Stéphane
Bancel
admits the company cannot
move new vaccines into Phase 3 trials due to insufficient U.S. market demand
which has historically been driven by mandates.
Bancel
suggests that with RFK Jr. at the helm of HHS, new vaccines are unlikely to
deliver acceptable returns on investment—an admission that highlights how
profit incentives, not public health needs, have long driven vaccine
development. Meanwhile, a broader reckoning is underway over mandates, industry
influence, and ethical lapses in vaccine testing at home and abroad, as calls
grow for stricter safety standards and meaningful accountability.
The
Wellness Group’s
Wellgineering
Bet
: A
First-of-Its-Kind Direct-to-Consumer CCM Model Aims to Fix What U.S. Healthcare
Keeps Breaking
T
his
represents the first serious attempt to bring Chronic Care Management (CCM)
directly to consumers at concierge scale, bypassing many of the institutional
bottlenecks that have long limited adoption.
Medical freedom movement,
choice, and technological disruption
:
needed ingredients to improve America’s
horribly broken healthcare system.
Alternative
Cancer Therapies and the FDA
Cancer is a devastating disease, and the mainline treatments
for cancer (e.g., drugs, surgery, radiation, etc.) are themselves painful,
risky, and have serious side-effects. As a result, many researchers,
doctors, and other professionals have questioned the mainstream paradigms, and
offered their own solutions to the cancer problem (mainly treatments).
Most of these potential alternative solutions are fundamentally not as painful
or physically devastating as the mainstream treatments,
have been labelled
alternative
therapies
, and
most have not received approval by the FD
A. The
difference is FDA treatment is not entirely based on proven scientific evidence
or data.
The Clinical
Barrier
for Alternative Treatment
:
The
primary barrier to approval is not necessarily the substance itself but the
historic requirement and
absence of standardized manufacturing and multi-million-dollar clinical
trials
. Anecdotal evidence, regardless of its
volume, is historically legally insufficient for FDA approval. Not all historically
accepted treatment methods could show such evidence or better results, but new
treatments have a huge obstacle. Recently Only the Pharmaceuticals have enough
money to pay for such trials and there has been significant fraud documented in
past trials.
While supportive or complementary practices
may improve
health or
quality of life, none of the therapies reviewed have been shown to
individually to consistently
cure or reverse cancer in humans
.
Protocols consisting of several treatment aspects such as detoxification + have
not been considered.
The
Seamless Transition: FDA Treatment of Alternative Covid-19 Therapies
AI Conclusion: The Medical System is Corrupt and Broken. Most Authority
and Institutional Clinical Studies Built in Bias that Determined the Result.
Bias Free Trials Got the Opposite Result.
IaCRDfC
The U.S. Navy issued a rare and
revealing apology tied to its COVID-era policies—quietly acknowledging the
damage caused by mandates and disciplinary actions imposed on service members.
Once unthinkable, the apology signals a deeper reckoning as institutions begin
to confront the real-world consequences of pandemic decision-making.
Jefferey tracks a growing state-by-state
battle over medical freedom, as lawmakers push competing bills that either
expand vaccine mandates and reporting or restore informed consent, parental
rights, and bodily autonomy. Hear how this clash, playing out in places like
New Jersey, Michigan, Massachusetts, Iowa, Hawaii, and Florida, signals a
pivotal moment in who ultimately controls healthcare decisions: families or
Federal Agencies or the state.
A deep dive into the UK’s newly announced AI surveillance
system, described by officials as a
panopticon.
We unpack the origins of
the term and what it signals about the future of mass surveillance.
THE
PANOPTICON STATE: UK’S AI SURVEILLANCE EXPANSION
The UK is rapidly sliding toward a
full-scale surveillance state, embracing AI-driven policing, facial
recognition, and predictive crime models reminiscent of Jeremy Bentham’s
panopticon—now openly praised by government officials. This raises a deeper question:
as AI and automation erode privacy, purpose, and meaningful human activity, are
we trading freedom and dignity for the promise of efficiency?
Data obtained through a freedom of information request show
that in 2021 alone, the U.K.’s Medicines and Healthcare products Regulatory
Agency received 48,472 reports of adverse events linking the AstraZeneca
COVID-19 vaccine to heart conditions. U.K. public health authorities knew about
the
reports, but
continued to tell the public that the
vaccine was safe and effective. The data confirm the findings of a study by
Children’s Health Defense researchers.
As bogus fraud investigations rock Minnesota, autism
education providers are facing devastating funding cuts. Jennifer Larson of
Holland Center joins Del to explain how legitimate, long-standing programs are
now at risk, and how families are paying the price.
Autism provider and Holland Center
founder Jennifer Larson joins Del Bigtree to expose how Minnesota’s sweeping
response to a massive Medicaid fraud scandal is punishing the wrong people. Not
just targeting criminal actors, the state has frozen payments and deployed
AI-driven systems that delay reimbursements, pushing legitimate autism care
providers to the brink of closure.
As legitimate centers
struggle to keep their doors open, vulnerable children and families are caught
in the crossfire. Larson explains how a blunt, bureaucratic crackdown has
created a second crisis, one that threatens access to essential care.
Highwire+
In this new episode, Del
Bigtree goes
Off
The
Record
with
J
ennifer Larson
, Founder and CEO of the Holland Center. She sounds the alarm on an
often overlooked
crisis:
what happens to autistic children as they age
into adulthood
with little to no support
system waiting for them. Drawing from decades of firsthand experience, Larson
exposes the
looming financial, social,
and humanitarian consequences
of an autism
care system unprepared for the wave of adults aging out of childhood services, and
asks the hard questions few policymakers are willing to face.
Guest: Jennifer Larson
📅
January
29, 2026